Investment firm Needham increased its price target for Vaxcyte to $122 from $110 following positive Phase 3 trial results for Vaxcyte's VAX-31 pneumococcal vaccine. The vaccine met all primary endpoints in the OPUS-1 trial, showing noninferiority to competitors Pfizer and Merck's vaccines and stronger responses against some strains. This success highlights a major opportunity in the adult pneumococcal vaccine market, potentially worth $3-6 billion. Vaxcyte shares surged 57% after the announcement, signaling strong investor confidence.
Vaxcyte's recent Phase 3 trial success comes as 61 out of 100 health-sector US stocks tradable on Pluang rose today. For readers following health stocks, here is Pluang's market snapshot as of Oct 06, 2026 03:02 WIB: Cytokinetics Inc (CYTK) fell 4.59% to USD 62.59 with a typical hold time of 19 days, 10X Genomics Inc (TXG) rose 4.53% to USD 97.74 with 73% buy order activity and a typical hold time of 93 days, and Danaher Corporation (DHR) dropped 4.47% to USD 211.68 with 72% buy order activity and a typical hold time of 69 days.
Smithfield Foods has created a $250,000 Future Leaders Scholarship program at Christopher Newport University to support eight incoming business students with $7,500 annual scholarships renewable for up to four years. The program aims to help local st...
E-Power Inc.'s joint venture, Sunrise Guizhou, received RMB 110 million of a planned RMB 200 million capital increase, raising its registered capital and valuing the company at RMB 2 billion post-money. The funds will support business expansion, R&D,...
AS Tallinna Sadam has signed a €50 million unsecured loan agreement with Swedbank, with a 5-year term and interest based on 3-month Euribor plus a margin. The loan will be fully drawn on October 26, 2026, and matures on October 26, 2031. This financi...
AS Tallinna Sadam signed a €50 million unsecured loan agreement with AS Swedbank, maturing in five years with an interest rate based on 3-month Euribor plus margin. The loan, drawn on October 26, 2026, will be used to redeem bonds worth €50.4 million...
Vita Coco, a leading coconut water brand, has partnered with Homesick to create a limited-edition candle collection inspired by Vita Coco Treats flavors: Strawberries & Creme and Frosted Lemonade. The candles capture the essence of these flavors thro...
